T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Digimarc Corp
DMRC
$167M
| $356K | ﹤0.01% |
19,229
-12,472
| -39% | -$233K |
|
2302
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $354K | ﹤0.01% |
800
| – | – |
|
2303
Castle Biosciences
CSTL
$960M
| $353K | ﹤0.01% |
14,981
-1,615
| -10% | -$37.4K |
|
|
STR
2304
DELISTED
Sitio Royalties
STR
| $353K | ﹤0.01% |
+12,240
| New | +$354K |
|
|
GOOD
2305
Gladstone Commercial Corp
GOOD
$641M
| $351K | ﹤0.01% |
18,959
-4,746
| -20% | -$84.4K |
|
2306
Western New England Bancorp
WNEB
$282M
| $351K | ﹤0.01% |
37,100
+7,000
| +23% | +$63.8K |
|
2307
Oric Pharmaceuticals
ORIC
$1.42B
| $350K | ﹤0.01% |
59,339
| – | – |
|
2308
Ecovyst
ECVT
$1.09B
| $348K | ﹤0.01% |
39,248
+14,693
| +60% | +$135K |
|
2309
Bally's
BALY
$671M
| $347K | ﹤0.01% |
17,887
+5,028
| +39% | +$110K |
|
2310
MVB Financial
MVBF
$397M
| $347K | ﹤0.01% |
15,750
+4,652
| +42% | +$114K |
|
|
PRSU
2311
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $347K | ﹤0.01% |
14,238
+326
| +2% | +$10.1K |
|
2312
AMERISAFE
AMSF
$504M
| $346K | ﹤0.01% |
6,657
+171
| +3% | +$9.05K |
|
2313
Aldeyra Therapeutics
ALDX
$91.7M
| $345K | ﹤0.01% |
49,587
+15,200
| +44% | +$86.9K |
|
|
EGLE
2314
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $342K | ﹤0.01% |
6,855
+875
| +15% | +$43.9K |
|
2315
Microvision
MVIS
$89.7M
| $341K | ﹤0.01% |
9,665
+731
| +8% | +$34K |
|
2316
Vital Farms
VITL
$498M
| $339K | ﹤0.01% |
22,693
-5,496
| -19% | -$75.8K |
|
2317
Cimpress
CMPR
$2.4B
| $338K | ﹤0.01% |
12,227
+371
| +3% | +$9.62K |
|
|
TBCH
2318
Turtle Beach Corp
TBCH
$230M
| $338K | ﹤0.01% |
47,111
+364
| +0.8% | +$2.85K |
|
2319
Motorcar Parts of America
MPAA
$230M
| $337K | ﹤0.01% |
28,383
+1,914
| +7% | +$27.9K |
|
2320
Arcturus Therapeutics
ARCT
$223M
| $335K | ﹤0.01% |
19,769
+1,522
| +8% | +$26.5K |
|
2321
Enova International
ENVA
$6.52B
| $335K | ﹤0.01% |
8,730
-4,939
| -36% | -$180K |
|
2322
Joby Aviation
JOBY
$8.17B
| $335K | ﹤0.01% |
99,963
+16,707
| +20% | +$67.7K |
|
|
BAND
2323
Bandwidth Inc
BAND
$1.67B
| $334K | ﹤0.01% |
14,537
-16,661
| -53% | -$303K |
|
2324
HealthStream
HSTM
$849M
| $334K | ﹤0.01% |
13,450
+388
| +3% | +$9.31K |
|
2325
Northrim BanCorp
NRIM
$599M
| $330K | ﹤0.01% |
24,204
+4,904
| +25% | +$61.9K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.